Raleigh drug firm lands FDA approval for treatment of intestinal infection affecting millions
The Citizen
RedHill Biopharma has received FDA approval for a treatment of a potentially deadly intestinal disease that affects 2 million people annually in the US and millions more worldwide.
Source: WRAL News
